Surgical Science Sweden AB (publ) (STO:SUS)
Sweden flag Sweden · Delayed Price · Currency is SEK
59.75
+0.75 (1.27%)
Nov 4, 2026, 5:29 PM CET

STO:SUS Revenue

Surgical Science Sweden AB had revenue of 254.52M SEK in the quarter ending June 30, 2026, with 21.69% growth. This brings the company's total for the last twelve months to 1.02B, up 8.40% year-over-year. In the year 2025, Surgical Science Sweden AB had annual revenue of 992.34M with 12.25% growth. That makes Surgical Science Sweden AB the 22,349th largest company in the world by revenue and 284th in Sweden.

Revenue (ttm)
1.02B
Revenue Growth
+8.40%
P/S Ratio
2.98
Revenue / Employee
3.21M
Employees
319
Market Cap
3.05B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Educational Products 501.54M 50.5%
  • Industry/OEM 490.80M 49.5%

By Geography

Chart
  • Americas 636.87M 64.2%
  • Europe 185.70M 18.7%
  • Asia 142.11M 14.3%
  • Other 27.67M 2.8%
Fiscal year ended Dec 31, 2025 See the full STO:SUS breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025992.34M108.26M12.25%
Dec 31, 2024884.09M1.23M0.14%
Dec 31, 2023882.85M80.31M10.01%
Dec 31, 2022802.54M435.76M118.81%
Dec 31, 2021366.78M261.98M249.98%
Dec 31, 2020104.80M3.28M3.23%
Dec 31, 2019101.52M35.82M54.51%
Dec 31, 201865.70M4.22M6.86%
Dec 31, 201761.49M3.33M5.72%
Dec 31, 201658.16M5.76M10.99%
Dec 31, 201552.40M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Getinge AB34.46B
Swedish Orphan Biovitrum AB31.97B
Medicover AB27.33B
Sectra AB3.74B
CellaVision AB763.02M
Stille AB711.42M
Carasent AB389.84M
Hansa Biopharma AB189.46M
Revenue Rankings